SubjectWell Acquires Trial24
SubjectWell bolsters its global patient recruitment capabilities by acquiring Trials24. The merger combines SubjectWell’s accuracy, diverse patient pool, and...
Jon Napitupulu
DeepCure: Unveiling the Potential of BD2 Inhibitor DC-9476 in Macrophage Activation Syndrome
DeepCure, a company employing AI for drug discovery, will present preclinical data on their BRD4 Inhibitor, DC-9476, at the...
Ferrer Headway with First Phase II Participant
Ferrer, a B Corp-certified pharmaceutical company, has initiated a Phase II clinical trial, PROSPER, to assess the safety and...
CD137 Antibodies: A Promising Cancer Immunotherapy Target
CD137 (4-1BB) is a promising target for cancer immunotherapy. Its ability to stimulate T cells and enhance tumor cell...
Introducing NTx Services: Revolutionizing Next-Gen mRNA Research
Nature’s Toolbox (NTx) has launched NTx Services, providing high-integrity, complex mRNA production using its innovative NTxscribe® RNA manufacturing system....
Tivic Health Study Ready for Enrollment With Non-Invasive Vagus Nerve Stimulation Technology
Tivic Health has received approval for the next phase of clinical research on its non-invasive cervical vagus nerve stimulation...
Azitra Gets Fast Track for EGFRi-Associated Skin Toxicity
Azitra, a biopharmaceutical company specializing in precision dermatology, has announced the FDA’s Fast Track Designation for ATR-04, a novel...
Fasenra: A Breakthrough in Treating Eosinophilic Granulomatosis with Polyangiitis
AstraZeneca‘s FASENRA (benralizumab) has received FDA approval for treating adults with eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune...
New Zeposia Data Reveal Durable Efficacy and Unwavering Safety in Relapsing MS
According to new data, a Phase 3 extension study of Zeposia for multiple sclerosis (MS) found a sustained decrease...
FDA Approves Keytruda® Plus Pemetrexed and Platinum Chemotherapy for Malignant Pleural Mesothelioma
The U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, in combination with pemetrexed and platinum chemotherapy, as a...